Statements (24)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:CEO |
gptkb:Ahn_Jae-yong
|
| gptkbp:collaboratedWith |
gptkb:AstraZeneca
gptkb:Bill_&_Melinda_Gates_Foundation gptkb:Sanofi gptkb:Coalition_for_Epidemic_Preparedness_Innovations_(CEPI) |
| gptkbp:country |
gptkb:South_Korea
|
| gptkbp:founded |
2018
|
| gptkbp:headquarters_location |
gptkb:Seongnam,_South_Korea
|
| https://www.w3.org/2000/01/rdf-schema#label |
SK Bioscience
|
| gptkbp:industry |
gptkb:biotechnology
pharmaceuticals |
| gptkbp:notableProject |
gptkb:GBP510_COVID-19_vaccine
|
| gptkbp:numberOfEmployees |
over 1,000
|
| gptkbp:parentOrganization |
gptkb:SK_Group
|
| gptkbp:product |
vaccine
vaccines cell culture-based influenza vaccine |
| gptkbp:stockExchange |
gptkb:KRX_(Korea_Exchange)
|
| gptkbp:stockSymbol |
302440
|
| gptkbp:website |
https://www.skbioscience.co.kr
|
| gptkbp:bfsParent |
gptkb:SK_Group
gptkb:AstraZeneca_COVID-19_vaccine |
| gptkbp:bfsLayer |
5
|